Back
NewAmsterdam Pharma Co. NV Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
51
NAMS
NewAmsterdam Pharma Co. NV
Last Price:
$35.47
Seasonality Move:
-4.57%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NAMS is experiencing slight buying pressure.
NewAmsterdam Pharma Co. NV Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 35.34 | Sell |
| 20-day SMA: | 34.14 | Buy |
| 50-day SMA: | 34.06 | Buy |
| 200-day SMA: | 28.94 | Buy |
| 8-day EMA: | 35.06 | Sell |
| 20-day EMA: | 34.56 | Sell |
| 50-day EMA: | 34.35 | Sell |
| 200-day EMA: | 30.34 | Buy |
NewAmsterdam Pharma Co. NV Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.44 | Buy |
| Relative Strength Index (14 RSI): | 49.21 | Sell |
| Chaikin Money Flow: | 163808 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (32.4 - 35.42) | Buy |
| Bollinger Bands (100): | (33.12 - 37.9) | Sell |
NewAmsterdam Pharma Co. NV Technical Analysis
| Feb 12 | Feb 13 | Feb 17 | Feb 18 | Feb 19 | Feb 20 | Feb 23 | Feb 24 | Feb 25 | Feb 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb | ||||||||||
| 12 | 13 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for NewAmsterdam Pharma Co. NV Stock
Is NewAmsterdam Pharma Co. NV Stock a Buy?
-
NewAmsterdam Pharma Co. NV share price is 34.28 while NAMS 8-day simple moving average is 35.34, which is a Sell signal.
-
The stock price of NAMS is 34.28 while NewAmsterdam Pharma Co. NV 20-day SMA is 34.14, which makes it a Buy.
-
NewAmsterdam Pharma Co. NV 50-day simple moving average is 34.06 while NAMS share price is 34.28, making it a Buy technically.
-
NAMS stock price is 34.28 and NewAmsterdam Pharma Co. NV 200-day simple moving average is 28.94, creating a Buy signal.
NAMS Technical Analysis vs Fundamental Analysis
Buy
51
NewAmsterdam Pharma Co. NV (NAMS)
is a Buy
Is NewAmsterdam Pharma Co. NV a Buy or a Sell?
-
NewAmsterdam Pharma Co. NV stock is rated a BuyThe current NewAmsterdam Pharma Co. NV [NAMS] share price is $34.28. The Score for NAMS is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
NewAmsterdam Pharma Co. NV Stock Info
Market Cap:
3.9B
Price in USD:
34.28
Share Volume:
900.9K
NewAmsterdam Pharma Co. NV 52-Week Range
52-Week High:
42.00
52-Week Low:
14.06
Buy
51
NewAmsterdam Pharma Co. NV (NAMS)
is a Buy
NewAmsterdam Pharma Co. NV Share Price Forecast
-
What is the NewAmsterdam Pharma Co. NV stock price today?The NewAmsterdam Pharma Co. NV stock price is 34.28 USD today.
-
Will NAMS stock go up or go down?NewAmsterdam Pharma Co. NV> share price is forecast to RISE/FALL based on technical indicators
-
Is NewAmsterdam Pharma Co. NV overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, NewAmsterdam Pharma Co. NV is not overvalued.
Is NewAmsterdam Pharma Co. NV Stock a Buy?
-
NewAmsterdam Pharma Co. NV share price is 34.28 while NAMS 8-day exponential moving average is 35.06, which is a Sell signal.
-
The stock price of NAMS is 34.28 while NewAmsterdam Pharma Co. NV 20-day EMA is 34.56, which makes it a Sell.
-
NewAmsterdam Pharma Co. NV 50-day exponential moving average is 34.35 while NAMS share price is 34.28, making it a Sell technically.
-
NAMS stock price is 34.28 and NewAmsterdam Pharma Co. NV 200-day simple moving average is 30.34, creating a Buy signal.
Fundamental Analysis of NewAmsterdam Pharma Co. NV
Is NewAmsterdam Pharma Co. NV a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.10 per share, an increase next quarter of $0.02 per share, a decrease this year of $0.43 per share, and an increase next year of $0.66 per share.
Technical Analysis of NewAmsterdam Pharma Co. NV
Should I short NewAmsterdam Pharma Co. NV stock?
-
NAMS Moving Average Covergence Divergence (MACD) indicator is 0.44, suggesting NewAmsterdam Pharma Co. NV is a Buy
-
NewAmsterdam Pharma Co. NV Relative Strength Index (RSI) is 49.21, which suggest NewAmsterdam Pharma Co. NV is oversold
-
The Bollinger Bands (25) for NewAmsterdam Pharma Co. NV is (32.4 - 35.42), which suggest NewAmsterdam Pharma Co. NV is a Sell
-
The Bollinger Bands (100) for NewAmsterdam Pharma Co. NV is (33.12 - 37.9), which suggest NewAmsterdam Pharma Co. NV is a Sell
* NewAmsterdam Pharma Co. NV stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.